{"id":"tp-48917","type":"article-newspaper","title":"United Therapeutics Q3 Revenue Rises 4% as Net Income Falls 24%","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48917","datePublished":"2026-11-05T00:58:34.000Z","dateModified":"2026-11-05T00:58:34.000Z","language":"en","abstract":"Diluted earnings per share declined 20% to $5.71, while research and development expense more than doubled to $279.2 million.","section":"Business","references":[]}